CYPH
Cypherpunk Technologies Inc.NASDAQFINANCIAL SERVICESASSET MANAGEMENT
Key Statistics
Market Cap
$127.76M
P/E Ratio
—
EPS
$-0.02
Beta
-0.10
52W High
$3.70
52W Low
$0.23
50-Day MA
$0.91
200-Day MA
$0.82
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Cypherpunk Technologies Inc.
Cypherpunk Technologies Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. The company is headquartered in Cambridge, Massachusetts.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-36.69M |
| Operating Margin | 0.00% |
| Return on Equity | -108.20% |
| Return on Assets | -26.20% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.90 |
| Price-to-Book | 1.51 |
| Price-to-Sales (TTM) | 160.10 |
| EV/Revenue | - |
| EV/EBITDA | 11.21 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $106.46M |
| Float | $89.12M |
| % Insiders | 7.35% |
| % Institutions | 15.29% |
Historical Volatility
HV 10-Day
144.32%
HV 20-Day
126.70%
HV 30-Day
116.33%
HV 60-Day
138.86%
HV Rank
—
Volatility is currently expanding
More FINANCIAL SERVICES Stocks
Data last updated: 5/25/2026